c-Src induces phosphorylation and translocation of p47phox: Role in superoxide generation by angiotensin II in human vascular smooth muscle cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 6, 2003, Pages 981-987

  Touyz, R M ^a   Yao, G ^a   Schiffrin, E L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Arteries; Reactive oxygen species; Tyrosine kinases

Indexed keywords

ANGIOTENSIN; GLYCOPROTEIN GP 91; PHOSPHOSERINE; PROTEIN; PROTEIN P22; PROTEIN P47; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ARTERY; ARTICLE; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NONHUMAN; NORMAL HUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEIN TRANSPORT; SMOOTH MUSCLE FIBER; VASCULAR TISSUE;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; CORTACTIN; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; MICE; MICROFILAMENT PROTEINS; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN SUBUNITS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS PP60(C-SRC); PYRIMIDINES; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; SUPEROXIDES;

EID: 0037783377     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000069236.27911.68     Document Type: Article

References (43)

1. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52:639-672.
2. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol. 2000;279:L1005-L1028.
3. Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2001;82:47-95.
4. Haddad JJ. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signaling. 2002;14:879-897.
5. Touyz RM. Oxidative stress and vascular damage in hypertension. Curr Hypertens Rep. 2000;2:98-105.
6. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg G, McMurray JJV, Dominiczak AF. An investigation into the sources of superoxide production in human blood vessels: Ang II increases superoxide production in human internal mammary arteries. Circulation. 2000;101:2206-2212.
7. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
8. Babior BM. NADPH oxidase: an update. Blood. 1999;93:1464-1476.
9. Babior BM, Lambeth JD, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys. 2002;397:342-344.
10. phox. J Biol Chem. 1996;271:17013-17020.
11. Gu Y, Xu YC, Wu RF, Souza RF, Nwariaku FE, Terada LS. TNFα activates c-Jun amino terminal kinase through p47phox. Experimental Cell Research. 2002;272:62-74.
12. Li JM, Mullen AM, Yun S, Wientjes F, Brouns GY, Thrasher AJ, Shah AM. Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha. Circ Res. 2002;90:143-50.
13. Bankers-Fulbright JL, Kita H, Gleich GJ, O'Grady SM. Regulation of human eosinophil NADPH oxidase activity: a central role for PKCdelta. J Cell Physiol. 2001;89:306-15.
14. Wolf G. Free radical production and angiotensin. Curr Hypertens Rep. 2000;2:167-173.
15. Lasssègue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lamberth JD, Griendling KK. Novel gp91phox homologues in vascular smooth muscle cells: nox 1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res. 2001;88:888-894.
16. Touyz RM, Schiffrin EL. Ang II-stimulated generation of reactive oxygen species in human vascular smooth muscle cells is mediated via PLD-dependent pathways. Hypertension. 1999;34(part 2):976-982.
17. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, Schiffrin EL. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res. 2002;90:1205-1213.
18. Touyz RM, Schiffrin EL. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent, NAD(P)H oxidase-sensitive pathways. J Hypertens. 2001;19:1245-1254.
19. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res. 2002;91:406-413.
20. Martin GS. The hunting of the Src. Nature Rev. 2001;2:467-475.
21. Oda Y, Renaux B, Bjorge J, Saifeddine M, Fujita DJ, Hollenberg MD. c-Src is a major cytosolic tyrosine kinase in vascular tissue. Can J Physiol Pharmacol. 1999;77:606-617.
22. Mureebe L, Nelson PR, Yamamura S, Lawitts J, Kent C. Activation of pp60c-Src is necessary for human vascular smooth muscle cell migration. Surgery. 1997;122:138-145.
23. 2+ signaling by angiotensin II in human vascular smooth muscle cells. J Hypertens. 2001;19:441-449.
24. Touyz RM, He G, Wu XH, Park JB, El Mabrouk M, Schiffrin EL. Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients. Hypertension. 2001;38:56-64.
25. Yang S, Hardaway M, Sun G, Ries WL, Key L Jr. Superoxide generation and tyrosine kinase. Biochem Cell Biol. 2000;78:11-17.
26. Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell. 1991;64:693-702.
27. Pou S, Huang YI, Bhan A, Bhadti VS, Hosmane RS, Wu SY, Cao GL, Rosen GM. A fluorophore-containing nitroxide as a probe to detect superoxide and hydroxyl radical generated by stimulated neutrophils. Anal Biochem. 1993;212:85-90.
28. Stolk J, Hiltermann TIN, Dijkman JH, Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol. 1994;11:95-192.
29. Tampo Y, Tsukamoto M, Yonaha M. Superoxide production from paraquat evoked by exogenous NADPH in pulmonary endothelial cells. Free Rad Biol Med. 1999;27:588-595.
30. Miller JM, Griendling KK. Functional evaluation of nonphagocytic NAD(P)H oxidases. Methods Enzymol. 2002;353:220-233.
31. Burritt JB, Quinn MT, Jutila MA, Bond CW, Jesaitis AJ. Topological mapping of neutrophil cytochrome b epitopes with phage-display libraries. J Biol Chem. 1995;270:16974-16980.
32. Touyz RM, Wu X-H, He G, Salomon S, Schiffrin EL. Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension. 2002;39:479-485.
33. Ma YC, Huang XY. Novel regulation and function of Src tyrosine kinase. Cell Mol Life Sci. 2002;59:456-462.
34. Zafari AM, Ushio-Fukai M, Minieri CA, Akers M, Lassegue B, Griendling KK. Arachidonic acid metabolites mediate angiotensin II-induced NADH/NADPH oxidase activity and hypertrophy in vascular smooth muscle cells. Antioxid Redox Signal. 1999;1:167-179.
35. Brumell JH, Burkhardt AL, Bolen JB, Grinstein S. Endogenous reactive oxygen intermediates activate tyrosine kinases in human neutrophils. J Biol Chem. 1996;271:1455-1461.
36. Lynch OT, Giembycz MA, Barnes PJ, Lindsay MA. Pharmacological comparison of LTB4-induced NADPH oxidase activation in adherent and non-adherent guinea-pig eosinophils. Br J Pharmacol. 2001;134:797-806.
37. Didichenko SA, Tilton B, Hemmings BA, Ballmer-Hofer K, Thelen M. Constitutive activation of protein kinase B and phosphorylation of p47phox by a membrane-targeted phosphoinositide 3-kinase. Curr Biol. 1996;6:1271-1278.
38. Fontayne A, Dang PM, Gougerot-Pocidalo MA, El-Benna J. Phosphorylation of p47phox sites by PKC alpha, beta II, delta and zeta: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry. 2002;41:7743-7750.
39. Shalom-Barak-T, Knaus UG. A p21-activated kinase-controlled metabolic switch up-regulated phagocyte NADPH oxidase. J Biol Chem. 2002;277:40659-40665.
40. Dang PM, Fontayne A, Hakim J, El Benna J, Perianin A. Protein kinase C zeta phosphorylates a subset of selective sites of the NADPH oxidase component p47phox and participates in formyl peptide-mediated neutrophil respiratory burst. J Immunol. 2001;166:1206-1213.
41. Reeves EP, Dekker LV, Forbes LV, Wientjes FB, Grogan A, Pappin DJ, Segal AW. Direct interaction between p47phox and protein kinase C: evidence for targeting of protein kinase C by p47phox in neutrophils. Biochem J. 1999;344:859-866.
42. Waite KA, Wallin R, Qualliotine-Mann D, McPhail LC. Phosphatidic acid-mediated phosphorylation of the NADPH oxidase component p47-phox: evidence that phosphatidic acid may activate a novel protein kinase. J Biol Chem. 1997;272:15569-15578.
43. Pagano PJ, Chanock SJ, Siwik DA, Colucci WS, Clark JK. Ang II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension. 1998;32:331-337.